Trexquant Investment LP purchased a new position in shares of Liquidia Co. (NASDAQ:LQDA - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 18,740 shares of the company's stock, valued at approximately $220,000.
Several other institutional investors and hedge funds also recently made changes to their positions in the company. Geode Capital Management LLC grew its holdings in Liquidia by 8.2% during the 4th quarter. Geode Capital Management LLC now owns 1,339,254 shares of the company's stock worth $15,753,000 after acquiring an additional 101,597 shares during the last quarter. Diametric Capital LP lifted its holdings in shares of Liquidia by 6.2% during the fourth quarter. Diametric Capital LP now owns 132,028 shares of the company's stock worth $1,553,000 after purchasing an additional 7,696 shares during the period. LM Advisors LLC bought a new stake in shares of Liquidia in the fourth quarter worth $25,948,000. Mitsubishi UFJ Asset Management Co. Ltd. increased its holdings in Liquidia by 13.3% in the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 172,172 shares of the company's stock valued at $2,116,000 after purchasing an additional 20,171 shares during the period. Finally, EntryPoint Capital LLC bought a new position in Liquidia during the 4th quarter worth $154,000. Institutional investors and hedge funds own 64.54% of the company's stock.
Insider Transactions at Liquidia
In other Liquidia news, CFO Michael Kaseta sold 8,283 shares of the business's stock in a transaction that occurred on Monday, April 14th. The stock was sold at an average price of $13.57, for a total transaction of $112,400.31. Following the completion of the sale, the chief financial officer now directly owns 396,315 shares of the company's stock, valued at approximately $5,377,994.55. The trade was a 2.05 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Rajeev Saggar sold 2,445 shares of the stock in a transaction that occurred on Tuesday, January 21st. The stock was sold at an average price of $13.00, for a total value of $31,785.00. Following the completion of the sale, the insider now directly owns 267,943 shares of the company's stock, valued at approximately $3,483,259. This trade represents a 0.90 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 33,123 shares of company stock valued at $448,366 over the last three months. Corporate insiders own 30.10% of the company's stock.
Liquidia Trading Up 0.3 %
LQDA stock traded up $0.04 during trading on Friday, reaching $13.72. 597,870 shares of the stock were exchanged, compared to its average volume of 969,758. Liquidia Co. has a twelve month low of $8.26 and a twelve month high of $16.81. The firm's 50 day moving average is $14.65 and its 200 day moving average is $12.80. The firm has a market cap of $1.17 billion, a P/E ratio of -8.42 and a beta of 0.23.
Liquidia (NASDAQ:LQDA - Get Free Report) last posted its quarterly earnings results on Wednesday, March 19th. The company reported ($0.46) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.38) by ($0.08). The business had revenue of $2.92 million during the quarter, compared to analyst estimates of $4.60 million. Liquidia had a negative net margin of 765.38% and a negative return on equity of 163.21%. As a group, analysts predict that Liquidia Co. will post -1.51 earnings per share for the current fiscal year.
Analysts Set New Price Targets
A number of research firms have commented on LQDA. Scotiabank reiterated an "outperform" rating on shares of Liquidia in a research report on Thursday, March 20th. HC Wainwright reaffirmed a "buy" rating and set a $29.00 price target on shares of Liquidia in a research report on Thursday, March 20th. Wells Fargo & Company initiated coverage on Liquidia in a research report on Friday, December 20th. They issued an "overweight" rating and a $20.00 price objective for the company. Finally, Needham & Company LLC restated a "buy" rating and set a $25.00 target price on shares of Liquidia in a research report on Thursday, April 10th. One research analyst has rated the stock with a hold rating, six have issued a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, Liquidia presently has an average rating of "Buy" and a consensus price target of $26.63.
Get Our Latest Stock Report on Liquidia
About Liquidia
(
Free Report)
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).
See Also
Before you consider Liquidia, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Liquidia wasn't on the list.
While Liquidia currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
